Issue 1/2022
Content (34 Articles)
A systematic review and meta-analysis of efficacy and safety of Romosozumab in postmenopausal osteoporosis
S. Singh, S. Dutta, S. Khasbage, T. Kumar, J. Sachin, J. Sharma, S B Varthya
Effective communication regarding risk of fracture for individuals at risk of fragility fracture: a scoping review
Charlotte Beaudart, Mickael Hiligsmann, Nannan Li, E. Michael Lewiecki, Stuart Silverman
Changes in bone mineral density in Down syndrome individuals: a systematic review and meta-analysis
Y. Zhang, Z. Tian, S. Ye, Q. Mu, X. Wang, S. Ren, X. Hou, W. Yu, J. Guo
Time dependency in early major osteoporotic and hip re-fractures in women and men aged 50 years and older: a population-based observational study
W. D. Leslie, L. Yan, L. M. Lix, S. N. Morin
Fractures and fall injuries after hospitalization for seasonal influenza—a national retrospective cohort study
K. F. Axelsson, H. Litsne, M. Lorentzon
Prediction of imminent fracture risk in Canadian women and men aged 45 years or older: external validation of the Fracture Risk Evaluation Model (FREM)
Sören Möller, Michael K. Skjødt, Lin Yan, Bo Abrahamsen, Lisa M. Lix, Eugene V. McCloskey, Helena Johansson, Nicholas C. Harvey, John A. Kanis, Katrine Hass Rubin, William D. Leslie
Sex differences in recovery of quality of life 12 months post-fracture in community-dwelling older adults: analyses of the Australian arm of the International Costs and Utilities Related to Osteoporotic Fractures Study (AusICUROS)
J. Talevski, K.M. Sanders, J.J. Watts, G.C. Nicholson, E. Seeman, S. Iuliano, R. Prince, L. March, T. Winzenberg, G. Duque, P.R. Ebeling, F. Borgström, J.A. Kanis, A.L. Stuart, A. Beauchamp, S.L. Brennan-Olsen
Fractures in untreated patients with osteoporosis in Germany: an InGef healthcare insurance database analysis
Wolfgang Böcker, Indraraj Umesh Doobaree, Artak Khachatryan, Eugen Dornstauder, Robert Bartsch, Gavin Worth, Moushmi Singh, Doreen A. Kahangire
Correction to: Fractures in untreated patients with osteoporosis in Germany: an InGef healthcare insurance database analysis
W. Böcker, I. U. Doobaree, A. Khachatryan, E. Dornstauder, R. Bartsch, G. Worth, M. Singh, D. A. Kahangire
Secular trends of incidence and hospitalization cost of hip fracture in Tangshan, China
X.-l. Hou, J.-y. Liu, X.-h. Fan, N. Zhang, G.-l. Cao, Z.-b. Guo, Y.-y. Zhang, Y.-h. Yu, Y.-q. Tian, X.-x. Sun, F.-m. Tian
Thirty years of hip fracture incidence in Austria: is the worst over?
Hans Peter Dimai, Berthold Reichardt, Emanuel Zitt, Hans Concin, Oliver Malle, Astrid Fahrleitner-Pammer, Axel Svedbom, Wolfgang Brozek
FRAX-based intervention thresholds for Pakistan
H. Johansson, G. Naureen, R. Iqbal, L. Jafri, A. H. Khan, M. Umer, E. Liu, L. Vandenput, M. Lorentzon, E. V. McCloskey, J. A. Kanis, N. C. Harvey
Hip fracture predicts subsequent hip fracture: a retrospective observational study to support a call to early hip fracture prevention efforts in post-fracture patients
Emil Schemitsch, Jonathan D. Adachi, Jacques P. Brown, Jean-Eric Tarride, Natasha Burke, Thiago Oliveira, Lubomira Slatkovska
One- and 2-year incidence of osteoporotic fracture: a multi-cohort observational study using routinely collected real-world data
Sara Khalid, Carlen Reyes, Martin Ernst, Antonella Delmestri, Emese Toth, Cesar Libanati, Bo Abrahamsen, Daniel Prieto-Alhambra
Cultivating across “pockets of excellence”: challenges to sustaining efforts to improve osteoporosis care
Aaron T. Seaman, Melissa J. A. Steffen, Jennifer M. Van Tiem, Shylo Wardyn, Xiomara Santana, Karla L. Miller, Samantha L. Solimeo
Trends in fractures in patients with spondyloarthritis: a nationwide population-based study (TREND-EspA study)
Ramon Mazzucchelli, Raquel Almodovar, Elisa Dieguez-Costa, Natalia Crespi Villarias, Elia Pérez-Fernandez, Alberto García-Vadillo
Self-rated health status and activities of daily living in the first 12 months after fragility fractures of the pelvis—a prospective study on 134 patients
Juliana Hack, Benjamin Buecking, Lukas Strauch, Julia Lenz, Tom Knauf, Steffen Ruchholtz, Ludwig Oberkircher
Association between exposure to fine particulate matter and osteoporosis: a population-based cohort study
G. Adami, G. Cattani, M. Rossini, O. Viapiana, P. Olivi, G. Orsolini, E. Bertoldo, E. Fracassi, D. Gatti, A. Fassio
Craniocervical abnormalities in osteogenesis imperfecta type V
K. Ludwig, C. Seiltgens, A. Ibba, N. Saran, J. A. Ouellet, F. Glorieux, F. Rauch
One leg standing time predicts fracture risk in older women independent of clinical risk factors and BMD
B.A.M. Larsson, L. Johansson, D. Mellström, H. Johansson, K.F. Axelsson, N. Harvey, L. Vandenput, E. McCloskey, E. Liu, D. Sundh, J.A. Kanis, M. Lorentzon
Thyroid-stimulating hormone is associated with trabecular bone score and 5-year incident fracture risk in euthyroid postmenopausal women: the OsteoLaus cohort
C. Vendrami, P. Marques-Vidal, E. Gonzalez Rodriguez, D. Hans, G. Waeber, O. Lamy
Factors associated with changes in volumetric bone mineral density and cortical area in men with ankylosing spondylitis: a 5-year prospective study using HRpQCT.
A. Deminger, E. Klingberg, M. Lorentzon, M. Hedberg, H. Carlsten, L.T.H. Jacobsson, H. Forsblad-d’Elia
Fracture rates and economic outcomes in patients with osteoporosis prescribed risedronate gastro-resistant versus other oral bisphosphonates: a claims data analysis
Friederike Thomasius, Santiago Palacios, Asif Alam, Mitra Boolell, Francis Vekeman, Geneviève Gauthier
Cost-effectiveness of 3 versus 6 years of zoledronic acid treatment before bisphosphonate holiday for women with osteoporosis
S. Nayak, S. L. Greenspan
Teriparatide and pelvic fracture healing: a phase 2 randomized controlled trial
J.W. Nieves, F. Cosman, D. McMahon, M. Redko, I. Hentschel, R. Bartolotta, M. Loftus, J.J. Kazam, J. Rotman, J. Lane
Adherence to dosing schedule of denosumab therapy for osteoporosis during COVID-19 lockdown: an electronic medical record and pharmacy claims database study from Asia
Manju Chandran, Ying Hao, Ann Kerwen Kwee, Mcvin Hua Heng Cheen, Yun Ann Chin, Valerie Yun Ting Ng
Long-term persistence with denosumab: real-world data from the Austrian Osteoporosis Clinic (AOC). A retrospective data analysis
Ewald Boschitsch, Oliver Naegele, Anita Klinger, Harald Brix-Samoylenko
No association of anti-osteoporosis drugs with COVID-19-related outcomes in women: a nationwide cohort study
A. Atmaca, I. Demirci, C. Haymana, I. Tasci, I. Sahin, E. Cakal, N. Ata, S. Dagdelen, S. Salman, R. Emral, M. Sahin, O. Celik, T. Demir, D. Ertugrul, U. Unluturk, M. Caglayan, I. Satman, A. Sonmez
Normal bone health in young adults with 21-hydroxylase enzyme deficiency undergoing glucocorticoid replacement therapy
Juliano Henrique Borges, Daniel Minutti de Oliveira, Sofia Helena Valente de Lemos-Marini, Bruno Geloneze, Gil Guerra-Júnior, Ezequiel Moreira Gonçalves
Zoledronic acid and bone health in older adults with cognitive impairment
B.M. Churilla, S. Perera, S.L. Greenspan, N.M. Resnick, M.P. Kotlarczyk
A novel mutation in collagen gene COL1A2 associated with transient regional osteoporosis
M. Varenna, C. Crotti, M. T. Bonati, F. Zucchi, M. Gallazzi, R. Caporali
Denosumab-induced hypocalcemia in a patient with hyperthyroidism: a case report
S.Y. Park, J. Kim, H.Y. Chung
Primary hyperphosphatemic tumoral calcinosis: a case report
J. Huang, L.-G. Cao, T.-R. Zhang, S.-M. Li, Q.-Q. Meng
In memoriam: Bernardo Stolnicki
C. Zerbini, A. Orcesi Pedro, R. M. Pereira, M. Lazaretti-Castro, P. Halbout, C. Cooper